- Filed
- May 12, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 6, 2025 | 34.17M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $8.56M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $8.47M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $11.39M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $15.66M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $11.21M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $14.09M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $22.44M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $26.62M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $33.03M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $37.03M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $53.96M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $59.21M |
| Rd Expense | Q1 2025 · Mar 31, 2025 | $0 |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $18K |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 29.33M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $139K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$2.38M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $20.64M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $21.29M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.06 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.06 |
| Net Income | Q1 2025 · Mar 31, 2024 | −$1.73M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$1.32M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $3.06M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $19.61M |
| Revenue | Q1 2025 · Mar 31, 2024 | $22.68M |